Jan 29, 2014
Sirona Biochem Completes Global Exclusive Licensing Agreement with Obagi Medical Products
Sirona Biochem Corp . announced today the formal execution of the global exclusive licensing agreement with Obagi Medical Products for the commercialization of skin lightening compound TFC-849.
Merger And Acquisition Watch: Solta Medical Will Be Acquired Soon - Here Is Why
In August of 2012, I wrote an article detailing why Obagi Medical Products would be acquired soon.
Recently released market study: Obagi Medical Products, Inc. (OMPI) - ...
The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.
Obagi Medical Products, Inc. (OMPI) - Pharmaceuticals & Healthcare -...
Obagi Medical Products, Inc. is a pharmaceutical company, based in the US. The company develops, markets, and sells proprietary skin care systems in the physician-dispensed skin care market.